This month, we’re delighted to welcome two new UK-based companies to our portfolio: Level Zero Health, the startup putting a spotlight on hormone monitoring, and Magdrive, the spacetech company transforming space propulsion. Plus, we introduce new team members, share updates from our portfolio, and dive into the latest insights into AI. Read on for all our updates this month...
portfolio announcements
level zero health: revolutionizing hormone monitoring
Level Zero Health (RAC VII) is transforming hormone health by building a real-time, wearable monitoring device to improve care for IVF, menopause, testosterone therapy, and beyond. Traditional blood tests provide only a single snapshot — Level Zero Health’s nanotechnology and DNA-based biosensing will enable remote and non-invasive monitoring, paving the way for more personalized and data-driven care. We're proud to support them on this mission by leading their $6.9M pre-seed funding round, backing their vision to make precision hormone health accessible to all.
Founded by Ula Rustamova (ex-Palantir, deeptech entrepreneur) and Irene Jia (bioengineer, Imperial College London), the team combines expertise in software and science to bring next-generation diagnostics to millions. “We revolutionized blood pressure monitoring — now we’re doing the same for hormones,” said redalpine investor and board member, Philip.
Read more in TechCrunch.
magdrive: pioneering next-generation space propulsion
Satellites have faced a trade-off between maneuverability, efficiency, and sustainability in space for too long. Enter Magdrive (RAC VII). What sets Magdrive's electric spacecraft propulsion system apart is its unrivaled thrust and efficiency, which will allow spacecraft to travel farther and be more maneuverable than ever before. Magdrive uses solid metal as propellant – which could eventually even be sourced and refueled from recycled ‘space junk’ or asteroid mining.
We’re proud to lead Magdrive’s $10.5M seed round, with participation from Balerion, Founders Fund, Alumni Ventures, Outsized Ventures, 7percent Ventures, and Entrepreneur First Fund. With their first in-space test scheduled for June, Magdrive is set to redefine propulsion for the satellite industry and beyond. As our GP Harald puts it: “Magdrive’s breakthrough propulsion system will make ambitious space missions a reality."
Read more in TechCrunch.
portfolio news
The latest updates from our portfolio, in no particular order:
N26 (RAC II) is ramping up growth - now onboarding 200,000–250,000 new customers per month. After regulatory limits slowed expansion, the neobank is coming back stronger than ever, launching fee-free securities trading and competitive interest rates to attract premium users. Co-founder Valentin Stalf sees massive opportunity ahead: “The market is large and far from settled.” Read more in Handelsblatt.
ExpressionEdits (RAC VII) is joining forces with Boehringer Ingelheim to push the boundaries of gene therapy. Their Genetic Syntax Engine leverages AI-powered intron optimization to enhance therapeutic protein expression—reducing the need for high viral loads or repeat dosing. This collaboration marks a major step toward more effective and precise genetic treatments, improving patient outcomes while minimizing risks. Read more here.
LegalFly (RAC VII) has been named one of The Times’ 10 transformative AI innovations, highlighting its impact on contract management, compliance, and policy enforcement. By automating legal workflows, LegalFly helps organizations accelerate deal cycles, enhance accuracy, and navigate complex regulations with ease. This milestone reflects the team’s dedication to reshaping legal tech.
Read more in The Times.
Proxima Fusion (RAC VII) has just unveiled plans for its first-of-a-kind Stellarator fusion power plant, marking a major leap forward in the race to commercial fusion energy. Proxima's plans are being heralded as a breakthrough toward what physicists have long considered the holy grail of clean energy. Backed by decades of research from the Max Planck Institute for Plasma Physics, Proxima’s decision to go open-source underscores a commitment to collaboration and accelerating global progress toward fusion-powered electricity. Read more in The Wall Street Journal.
team announcements
We're delighted to introduce four new team members who have joined redalpine since the beginning of the year:
Florian Bieberich joins as an Analyst in Zurich. Florian holds a PhD in Synthetic and Systems Immunology from ETH Zürich and has experience as a Strategy Consultant at BCG, specializing in strategy and M&A projects in R&D at global biopharma companies.
Leonard Schmid joins as Investment Manager in Zurich. With over 5 years of experience at Speedinvest and a Master’s degree in Industrial Engineering from RWTH Aachen, Leonard brings deep expertise in venture capital and a passion for sustainable innovation.
Lezama Schneider joins as Principal in London for our multi-stage Summit Fund. Previously, Lezama held roles at Alanda Capital Management, Providence Equity Partners, and J.P. Morgan. Lezama holds a Bachelor of Science from EBS University for Business and Law.
Nicholas von Klitzing joins as an Analyst & AI Engineer in Zurich after working with us as a Visiting Analyst in 2024. Having earned a Bachelor’s degree in Economics from The Wharton School and worked as an Analyst at Swiss Founders Fund, Nicholas will now focus on AI and IT initiatives at redalpine.
event highlights
redalpine at Frankfurt Digital Finance
At Frankfurt Digital Finance, Sebastian joined a panel discussion on one of the biggest challenges for AI startups in Europe: Over-regulation and funding gaps.
While Europe has world-class AI talent, too many of its best founders are leaving for the U.S., drawn by faster scaling opportunities, fewer regulatory hurdles, and more capital availability. To stay competitive, Europe must create an environment where AI companies can build, scale, and thrive. Investing in AI applications, compliance tools, and breakthrough innovations like nuclear fusion is key.
With strong commitments from policymakers and investors, there’s momentum—but Europe must act now to turn its strengths into global leadership.
what we're reading
Why it matters: Scientists at Imperial College London spent 10 years unraveling why some superbugs resist antibiotics. Google’s AI tool solved it in 48 hours—and even proposed new hypotheses. This breakthrough highlights AI’s potential to accelerate scientific discovery, reshape medical research, and revolutionize problem-solving across disciplines. However, there are differing views on how broadly this success can be applied, and the full implications remain to be seen. Some experts believe this could lead to faster drug development and new ways to combat antibiotic resistance, a growing global health crisis.
where we're going
Goldman Sachs Disruptive Technology Symposium (March 4 - 5, London) – Marc will join this event, which brings European unicorns, investors, and business leaders together.
SECA Workshop on Evergreen Funds (March 13, Zurich) – Hosted by Coller Capital, this workshop will dive into the benefits and challenges of evergreen fund structures in venture capital. Rafael will join the discussion, bringing insights on how evergreen models fit into the broader VC ecosystem.
START Summit (March 19 - 21, St. Gallen) - Sebastian, Gianmarco, and more will be at START Summit, Switzerland’s largest startup conference. We’re proud to sponsor the event and will be hosting a dinner together with Balderton Capital on the 19th to kickoff the conference.
LP insights breakfast at invest europe flagship conference (March 21, Geneva) - Sebastian will co-host an exclusive LP insights breakfast with Atomico, uniting investors and policy leaders to tackle key trends and barriers in European tech investment.